Evidence map›Paper›PMID 11741199›Full record

ReviewAAPS pharmSci1999

The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors.

C B Felder, R C Graul, A Y Lee, H P Merkle, W Sadee

Open access · bronzeAbstract readReview
In one paragraph

Review in AAPS pharmSci, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 250 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genetically encoded sensors illuminateIBRO neuroscience reports · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Retracing the evolution of a modern periplasmic binding protein.Protein science : a publication of the Protein Society · 2023
    Article
  14. Article
  15. Structures of permuted halves of a modern ribose-binding protein.Acta crystallographica. Section D, Structural biology · 2023
    Article
  16. Article
  17. Article
  18. Crystal structure and metal binding properties of the periplasmic iron component EfeM from Pseudomonas syringae EfeUOB/M iron-transport system.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2022
    Article
  19. Review
  20. Review

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

C B FelderDepartment of Pharmacy, ETH Zurich, Winterthurerstr. 190, CH-8057 Zurich, Switzerland.
R C Graul
A Y Lee
H P Merkle
W Sadee
ETH Zurich · CHUniversity of California System · USNGM Biopharmaceuticals (United States) · US

Funding

USE OF MUCCOSAL CELL CARRIERS/EYZYMES IN ORAL ABSORPTIONR01GM037188 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AMIDON, GORDON L · 1986 to 2013
$4.4M
MUTATIONS OF MUSCARINIC CHOLINERGIC RECEPTOR GENESR01GM043102 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI SADEE, WOLFGANG · 1990 to 2001
$398k
NIGMS NIH HHS GM37188NIGMS NIH HHS GM43102
6 · The paper itself

Abstract

Located between the inner and outer membranes of Gram-negative bacteria, periplasmic binding proteins (PBPs) scavenge or sense diverse nutrients in the environment by coupling to transporters or chemotaxis receptors in the inner membrane. Their three-dimensional structures have been deduced in atomic detail with the use of X-ray crystallography, both in the free and liganded state. PBPs consist of two large lobes that close around the bound ligand, resembling a Venus flytrap. This architecture is reiterated in transcriptional regulators, such as the lac repressors. In the process of evolution, genes encoding the PBPs have fused with genes for integral membrane proteins. Thus, diverse mammalian receptors contain extracellular ligand binding domains that are homologous to the PBPs; these include glutamate/glycine-gated ion channels such as the NMDA receptor, G protein-coupled receptors, including metabotropic glutamate, GABA-B, calcium sensing, and pheromone receptors, and atrial natriuretic peptide-guanylate cyclase receptors. Many of these receptors are promising drug targets. On the basis of homology to PBPs and a recently resolved crystal structure of the extracellular binding domain of a glutamate receptor ion channel, it is possible to construct three-dimensional models of their ligand binding domains. Together with the extensive information available on the mechanism of ligand binding to PBPs, such models can serve as a guide in drug discovery.

Indexed as

Escherichia coli ProteinsEvolution, MolecularAnimalsArtificial Gene FusionBacterial ProteinsCarrier ProteinsCrystallography, X-RayDatabases, FactualGram-Negative BacteriaGTP-Binding ProteinsLac RepressorsLigandsMembrane Transport ProteinsModels, MolecularPeptidesProtein ConformationBacterial ProteinsCarrier ProteinsEscherichia coli ProteinsGTP-Binding ProteinsLac RepressorsLigandsMembrane Transport ProteinsPeptidesReceptors, DrugReceptors, GlutamateRepressor Proteins

Identifiers

PMID11741199
PMCPMC2761117
OpenAlexW2006304581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.